A Pilot Study of Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Phase of Trial: Phase II
Latest Information Update: 13 Aug 2017
At a glance
- Drugs Brentuximab vedotin (Primary) ; Dacarbazine; Doxorubicin; Vinblastine
- Indications Hodgkin's disease
- Focus Adverse reactions; Therapeutic Use
- 23 May 2017 Planned End Date changed from 1 May 2017 to 1 May 2018.
- 23 May 2017 Planned primary completion date changed from 1 May 2017 to 1 May 2018.
- 11 Oct 2016 Planned number of patients changed from 59 to 117.